chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/11, Moderna , dose #1 03/11, Moderna , dose #2 08/29 pt cc: chills, cough, fever, headache, fatigue, rhinorrhea, myalgias, exposure:  friend 08/31 COVID swab, result: detected 08/31 SARS-COV-2 LINEAGE b.1.617.2 08/31 SARS-COV-2 CLADE 21J DELTA
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Dyspnoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/05, Pfizer, dose #1 03/29, Pfizer, dose #2 08/13 pt cc: chills, cough, diarrhea, fatigue, headache, myalgias, dyspnea, exposure: friend 08/31 COVID swab, result: detected 09/21 COVID swab, result: not detected
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Fatigue, Headache, Myalgia, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/05, Pfizer, dose #1 03/29, Pfizer, dose #2 08/13 pt cc: chills, cough, diarrhea, fatigue, headache, myalgias, dyspnea, exposure: friend 08/31 COVID swab, result: detected 09/21 COVID swab, result: not detected
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, Oropharyngeal pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/16, Moderna , dose #1 04/13, Moderna , dose #2 08/30 pt cc: cough, rhinorrhea, sore throat, fatigue, dyspnea exposure: unknown 08/31 COVID swab, result: detected
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/16, Moderna , dose #1 04/13, Moderna , dose #2 08/30 pt cc: cough, rhinorrhea, sore throat, fatigue, dyspnea exposure: unknown 08/31 COVID swab, result: detected
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Narrative:  63 YO F with PMHx significant for PTSD, depression, HLD, obesity,  hypothyroidism, and migraines reported headache for ~1 week after 2nd COVID- 19 vaccination. Per recent PCP note, patient's headache have been controlled on current headache regimen (topiramate 100mg QAM and 200mg QPM+ sumatriptan 50mg prn). Patient did not seek medical assistance for reported sx.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Narrative: Patient with breakthrough covid infection. 1 dose of Janssen vaccine received 3 days prior to positive result. Treated with monoclonal antibody.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: Patient with breakthrough Covid infection. Previously received 2 doses of moderna vaccine. Treated with monoclonal antibodies
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Narrative: Patient with breakthrough covid infection. Janssen vaccine on 3/15/21 and covid positive test on 4/13/21. Treated with monclonal antibodies.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: Patient with covid breakthrough infection. Received 1 dose of moderna vaccine before and one after. Treated with monoclonal antibodies
Age: 79.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Influenza like illness, Vaccination site pain
Clinical narrative: Narrative:  Patient reported that he had significant arm pain at areas of vaccination administration and flu-like symptoms which lasted for 3 days approx 6 days after receiving both influenza vaccination and COVID-19 booster dose were given in the same arm on the same day. Patient wanted to reported ADR, did not pursue COVID testing, no additional symptoms.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Narrative: Patient with breakthrough covid infection. 1 dose of moderna prior to infection, 1 dose post infection. Treated with monoclonal antibodies.
Age: 53.0
Sex: M
Vaccine: VARZOS
Symptoms: Extra dose administered
Clinical narrative: Narrative:  Proper nursing procedures not following and patient received the incorrect vaccine. Pt received a 3rd dose of shingrix when only 2 doses is recommended. Pt was observed and suffered no harm from the extra dose. The vaccine not received will be rescheduled. Reporting since error involving a  vaccine. No harm to patient.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, fatigue, chills Narrative:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia
Clinical narrative: Myalgia, lymphadenopathy Narrative:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, CoughWheeze & Diarrhea Narrative:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Headache, Myalgia, Fever, CoughWheeze & Diarrhea Narrative:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Vomiting
Clinical narrative: Myalgia, NauseaVomiting, fatigue, headache,  Narrative:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: Myalgia, severe chills w/o fever Narrative:
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Headache, Malaise, Sedation
Clinical narrative: Confusion, Dizziness, Headache, Sedation, malaise Narrative:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue, Headache, Pain in extremity
Clinical narrative: Headache, chest tightness, fatigue (L) arm pain Narrative:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Injection site pain, Rhinorrhoea
Clinical narrative: Headache, soreness at injection site, bilateral shoulder pain, runny nose Narrative:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Tremor
Clinical narrative: Fever, CHILLS AND SHAKINESS Narrative:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pharyngeal paraesthesia
Clinical narrative: "tingling arms, legs and throat" Narrative: Employee complained of "tingling arms, legs and throat". Instructed to wait an additional 15 minutes for observation. Vitals signs WNL afterwards. Instructed to report to the ER if symptoms worsened or she felt it was warranted. She declined to go and left the clinic in no apparent distress.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain
Clinical narrative: Headache, injection site pain Narrative:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Brain fog, Fatigue, Gait disturbance, Headache
Clinical narrative: Headache, Myalgia, head fogginess, fatigue weakness, unsteady gait  Narrative: N/A
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Headache, Myalgia, head fogginess, fatigue weakness, unsteady gait  Narrative: N/A
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain
Clinical narrative: Headache injection site pain Narrative:
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Throat tightness
Clinical narrative: THROAT CLOSING IN AND HEAD CONGESTION Narrative:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Hyperhidrosis, Myalgia
Clinical narrative: Dizziness, Headache, Myalgia, Fever,  sweats, chills Narrative:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Dizziness, Headache, Myalgia, Fever,  sweats, chills Narrative:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Brain fog, Eye pruritus, Pruritus, Urticaria
Clinical narrative: UrticariaPruritus Head foggy, itchy eyes Narrative:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Myalgia, Pain in extremity, Swelling
Clinical narrative: Myalgia, Arthralgia, left arm soreness, redness, and swelling Narrative:
Age: 0.5
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Headache fatigue, rhinorrhea, sore throat Narrative:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Headache, Myalgia, Oedema peripheral, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, Swollen under the armpit and breast Narrative:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Peripheral swelling, Rhinorrhoea
Clinical narrative: Headache, Swollen arm, fatigue, runny nose,  Narrative:
Sex: M
Vaccine: COVID19
Symptoms: Injection site swelling, Lymphadenopathy, Myalgia
Clinical narrative: Myalgia Narrative: Swelling in l axillary lymph and on left deltoid at injection site
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Confusional state, Memory impairment, Movement disorder, Palpitations
Clinical narrative: Confusion, Headache, RespDepression, Tachycardia, abdominal pain, slight memory problems, SP02 91-93 X1 week, HR of 150+ at times, racing heart, problems with movement, continued  symptoms for months Narrative:  MD visits and 2 ER visits in April and June for ongoing problems; condition was still ongoing in June 2021 and unsure if it has  resolved now
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory depression, Tachycardia
Clinical narrative: Confusion, Headache, RespDepression, Tachycardia, abdominal pain, slight memory problems, SP02 91-93 X1 week, HR of 150+ at times, racing heart, problems with movement, continued  symptoms for months Narrative:  MD visits and 2 ER visits in April and June for ongoing problems; condition was still ongoing in June 2021 and unsure if it has  resolved now
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Tachycardia
Clinical narrative: Headache, Myalgia & Tachycardia Narrative: Continues to have prolonged Tachycardia.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain, Neck pain, Pain
Clinical narrative: INJECTION SITE PAIN, NECK PAIN, BODY ACHES, RIGHT KNUCKLE PAIN Narrative:
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia,  fatigue Narrative:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Insomnia, Myalgia
Clinical narrative: Headache, Myalgia, Fever INJECTION SITE PAIN, HEADACHE, CHILLS,  FEVER, INSOMNIA  Narrative:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache, Myalgia, Fever INJECTION SITE PAIN, HEADACHE, CHILLS,  FEVER, INSOMNIA  Narrative:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity
Clinical narrative: Headache ARM PAIN, HEADACHE, CHILLS Narrative:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye pain, Myalgia, Peripheral swelling, Pyrexia
Clinical narrative: Myalgia, Fever, redness & swelling left arm, eye pain Narrative:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Headache & Fever Narrative:
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity, Vomiting
Clinical narrative: Headache, NauseaVomiting, (L) sore arm Narrative:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Myalgia, Rash
Clinical narrative: Myalgia, Arthralgia, Rash, Chills, fatigue Narrative:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Haemorrhage, Headache, Heavy menstrual bleeding, Myalgia
Clinical narrative: Headache, Bleeding, Myalgia, Fever, triggered heavy painful menstrual cycle Narrative:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache, Bleeding, Myalgia, Fever, triggered heavy painful menstrual cycle Narrative:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, chills; soreness at injection site, fatigue Narrative:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, chills; soreness at injection site, fatigue Narrative:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue
Clinical narrative: dizzy weak tired Narrative:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Dizziness, Headache, Arthralgia, Fever, chills, dizziness, fatigue Narrative:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Dizziness, Headache, Arthralgia, Fever, chills, dizziness, fatigue Narrative:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Myalgia, Oedema peripheral, Pyrexia
Clinical narrative: Myalgia, Fever, fever of 100.3, swelling and pain of left axilla, fatigue Narrative: NA
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Pyrexia
Clinical narrative: Arthralgia, Fever & Diarrhea Narrative:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: General symptom, Lymphadenopathy
Clinical narrative: General symptoms: Swollen glands.  Narrative:
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pyrexia
Clinical narrative: Dizziness, Headache, Fever,  Employee's temperature is 99.9 Narrative:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Oedema peripheral
Clinical narrative: Headache, Myalgia,  fever 100.3, chills, swelling in L axilla, fatigue Narrative:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache, Myalgia,  fever 100.3, chills, swelling in L axilla, fatigue Narrative:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blindness, Inflammation, Myalgia, Photophobia
Clinical narrative: BlurredVision, Myalgia, Arthralgia, blindness when vehicle lights shine in eyes at night, generalized body inflammation Narrative:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: BlurredVision, Myalgia, Arthralgia, blindness when vehicle lights shine in eyes at night, generalized body inflammation Narrative:
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain
Clinical narrative: Fatigue and sore at injection site Narrative:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Myalgia, Pruritus, Urticaria
Clinical narrative: Dizziness, Headache, Myalgia & UrticariaPruritus Narrative: NOT SEVERE, MODERATE INTENSE PRURITIS TO CHES TAND BACK
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Injection site pain
Clinical narrative: Arthralgia Fatique , sore injection site Narrative:
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, fatigue, chills Narrative:
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pyrexia
Clinical narrative: Myalgia fatigue, feverish Narrative:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Dizziness, Headache, Sedation, Myalgia, fatigue, chills, sweating Narrative:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Sedation
Clinical narrative: Dizziness, Headache, Sedation, Myalgia, fatigue, chills, sweating Narrative:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pain, Vaccination site swelling
Clinical narrative: Dizziness, Headache, swollen on vaccine site, bodyache, fatigue Narrative:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymph node pain
Clinical narrative: armpit pain due to soreness of lymph nodes  Narrative:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia
Clinical narrative: Headache, Myalgia & Arthralgia Narrative:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Hyperhidrosis, Myalgia
Clinical narrative: Headache, Myalgia, CoughWheeze, NauseaVomiting, chills, sweating Narrative: referred to PCP/Urgent Care if sx persist. Empl. voiced understanding.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting, Wheezing
Clinical narrative: Headache, Myalgia, CoughWheeze, NauseaVomiting, chills, sweating Narrative: referred to PCP/Urgent Care if sx persist. Empl. voiced understanding.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Myalgia
Clinical narrative: Headache, Myalgia,  pain at injection site Narrative: NA
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Neck pain, Pain in extremity
Clinical narrative: Myalgia, Fever, Left arm soreness, left neck side soreness, fatigue, chills  Narrative:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Myalgia, Fever, Left arm soreness, left neck side soreness, fatigue, chills  Narrative:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, General symptom, Heart rate increased
Clinical narrative: General symptoms: SOB, Increased heart rate at times Narrative:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Discomfort, Fatigue, Headache, Myalgia
Clinical narrative: Local injection: Pain-discomfort. General Symptoms: Chills, headaches, muscle pains, fatigue, nausea, vomiting.   Narrative:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Vomiting
Clinical narrative: Local injection: Pain-discomfort. General Symptoms: Chills, headaches, muscle pains, fatigue, nausea, vomiting.   Narrative:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Discomfort, Fatigue
Clinical narrative: Local symptoms: Pain-discomfort, General Symptoms: Chills, headaches, joint pains, muscle pains, fatigue, Diarrhea.  Narrative:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain
Clinical narrative: Local symptoms: Pain-discomfort, General Symptoms: Chills, headaches, joint pains, muscle pains, fatigue, Diarrhea.  Narrative:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash Narrative:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Malaise, Myalgia
Clinical narrative: Headache, Myalgia, malaise, pain at injection site Narrative: Na
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia & Fever Narrative:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling of body temperature change, Hot flush, Hyperhidrosis, Tremor
Clinical narrative: sweaty hands, shaking, hot/cold flashes Narrative:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: Headache, Myalgia,  chills Narrative:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: SkinRash, pruritus Narrative:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Injection site swelling, Lymphadenopathy
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia, Fever, NauseaVomiting, Chills, Swollen glands, Swelling at injection site Narrative:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia, Fever, NauseaVomiting, Chills, Swollen glands, Swelling at injection site Narrative:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia, Respiratory tract congestion
Clinical narrative: Headache, Myalgia, Fever, CHILLS, CONGESTION,  Narrative:
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, General symptom, Hyperhidrosis, Pain
Clinical narrative: Local symptoms: Pain-discomfort, General symptoms: fatigue, sweating. Narrative:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Oropharyngeal pain, Pyrexia
Clinical narrative: Headache, Fever, sore throat, pain at injection site Narrative: Employee states that she developed symptoms this morning after receiving vaccine yesterday.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Headache, Myalgia, Pain, Skin warm
Clinical narrative: Headache, Myalgia, skin hot but not flushed, increased anxiety  Narrative: Employee states hot skin with out flushing, increased anxiety, generalized body ache
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Myalgia, Fever & NauseaVomiting Narrative:
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Injection site pain
Clinical narrative: arm pain at injection site and chills Narrative:
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Eye irritation, Lymphadenopathy, Nausea, Swelling face
Clinical narrative: Dizziness, NauseaVomiting, lymph node swelling under arm, face swelling and eyes burning Narrative:
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Dizziness, NauseaVomiting, lymph node swelling under arm, face swelling and eyes burning Narrative:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Myalgia, Pain
Clinical narrative: Headache & Myalgia Narrative: Missed days 10/7-10/8/2021 Symptoms: Headache, chills, body ache and injection site pain
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arm, fatigue Narrative:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain, Myalgia, Nausea, Vomiting
Clinical narrative: Myalgia, Arthralgia, NauseaVomiting, injection site pain Narrative:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia
Clinical narrative: Myalgia, Arthralgia, fatgue Narrative:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Hyperhidrosis, Oropharyngeal pain
Clinical narrative: Arthralgia CHILLS, SWEATS, SORE THROAT, Narrative:
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pyrexia
Clinical narrative: Myalgia, Arthralgia & Fever Narrative:
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Diarrhoea, Fatigue, Headache, Neck pain
Clinical narrative: Headache, Fever, Diarrhea, fatigue, pain upper back and neck Narrative:
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache, Fever, Diarrhea, fatigue, pain upper back and neck Narrative:
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Malaise, Myalgia
Clinical narrative: Headache, Myalgia, Diarrhea, malaise Narrative:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Myalgia, Sneezing
Clinical narrative: Headache, Myalgia, malaise, sneezing Narrative:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration, Pain, Rash, Tenderness
Clinical narrative: SkinRash  Pain and tenderness with 3-4 hours of injection. Redness induration  Narrative:
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: Headache, Diarrhea,  Fatigue, chills Narrative:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Headache, Hot flush
Clinical narrative: Headache HOT FLASHES,SHORT OF BREATH Narrative:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, chills Narrative:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Injection site erythema, Injection site pain, Myalgia
Clinical narrative: Myalgia, Fever, CHILLS, BODY ACHES, COUGH, L PAIN/REDNESS AT INJECTION SITE  Narrative:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Myalgia, Fever, CHILLS, BODY ACHES, COUGH, L PAIN/REDNESS AT INJECTION SITE  Narrative:
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: No information known other than that patient's daughter reported his death which occurred the day after the patient received the COVID-19 and influenza vaccine.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pain in extremity
Clinical narrative: ARM PAIN, LIGHTHEADEDNESS, NAUSEA Narrative:
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Injection site pain, Myalgia
Clinical narrative: Myalgia, Arthralgia,  fatigue, injection site pain Narrative:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain
Clinical narrative: Headache FATIGUE AND LEFT ARM INJECTION SITE  PAIN  Narrative:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Injection site pain, Myalgia
Clinical narrative: Headache, Myalgia, NauseaVomiting, left arm injection site pain, chills, fatique, Narrative:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Headache, Myalgia, NauseaVomiting, left arm injection site pain, chills, fatique, Narrative:
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Injection site pain, Myalgia, Pain
Clinical narrative: Myalgia, Arthralgia, body aches, fatigue, sore at injection site Narrative: The day after receiving the first dose of the Pfizer COVID-19 vaccine, she reported experiencing fatigue, body aches, and pain at the injection site. She treated herself by resting, drinking lot of fluids, and taking acetaminophen (dosing unknown).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac flutter, Electrocardiogram ambulatory, Heart rate irregular, Palpitations, Tachycardia
Clinical narrative: Palpitations, Tachycardia, irregular heart beats, fluttering, sudden heart racing Narrative:  A week after receiving the second dose of Pfizer COVID-19 vaccine, the patient reported feeling like her heart was racing. After another week, she went to the ER with "irregular heart beat". She was referred to a cardiologist and is in the process of wearing a Holter monitor as part of further workup.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, Lightheadedness, fatigue Narrative:
Sex: U
Vaccine: HEP
Symptoms: Product dispensing error, Recalled product administered
Clinical narrative: lot number involved in a RECALL was administered; lot number involved in a RECALL was administered; This case was reported by a nurse via call center representative and described the occurrence of recalled drug administered in a patient who received HBV (Engerix B) (batch number CP23D, expiry date 31st December 2023) for prophylaxis.   On an unknown date, the patient received Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details provided were as follows: Age at vaccination was not reported. The patient received recalled dose of Engerix B which led to recalled drug administered and drug dispensing error. Immediately all the product were quarantined from this lot. The product was stopped distributing and administering this lot only. Nurse would like to know if 10 patients received Engerix-B of lot number CP23D. The nurse asked do they need to inform patients and revaccinate them and do they need to report this situation. The reporter consented to follow-up. This case was 1 of 10 case linked case with this case.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR223912:same reporter US-GLAXOSMITHKLINE-US2021222775:same reporter US-GLAXOSMITHKLINE-US2021AMR223917:same reporter US-GLAXOSMITHKLINE-US2021AMR223914:same reporter US-GLAXOSMITHKLINE-US2021AMR223920:same reporter US-GLAXOSMITHKLINE-US2021AMR223919:same reporter US-GLAXOSMITHKLINE-US2021AMR223913:same reporter US-GLAXOSMITHKLINE-US2021AMR223915:same reporter US-GLAXOSMITHKLINE-US2021AMR223916:same reporter
Sex: U
Vaccine: HEP
Symptoms: Product dispensing error, Recalled product administered
Clinical narrative: lot number involved in a RECALL was administered; lot number involved in a RECALL was administered; This case was reported by a nurse via call center representative and described the occurrence of recalled drug administered in a patient who received HBV (Engerix B) (batch number CP23D, expiry date 31st December 2023) for prophylaxis.   On an unknown date, the patient received Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details provided were as follows: Age at vaccination was not reported. The patient received recalled dose of Engerix B which led to recalled drug administered and drug dispensing error. Immediately all the product were quarantined from this lot. The product was stopped distributing and administering this lot only. Nurse would like to know if 10 patients received Engerix-B of lot number CP23D. The nurse asked do they need to inform patients and revaccinate them and do they need to report this situation. The reporter consented to follow-up. This case was 1 of 10 linked cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021222775:same reporter US-GLAXOSMITHKLINE-US2021AMR223912:same reporter US-GLAXOSMITHKLINE-US2021AMR223913:same reporter US-GLAXOSMITHKLINE-US2021AMR223920:same reporter US-GLAXOSMITHKLINE-US2021AMR223914:same reporter US-GLAXOSMITHKLINE-US2021AMR223915:same reporter US-GLAXOSMITHKLINE-US2021AMR223916:same reporter US-GLAXOSMITHKLINE-US2021AMR223918:same reporter US-GLAXOSMITHKLINE-US2021AMR223919:same reporter
Sex: U
Vaccine: HEP
Symptoms: Product dispensing error, Recalled product administered
Clinical narrative: lot number involved in a RECALL was administered; lot number involved in a RECALL was administered; This case was reported by a nurse via call center representative and described the occurrence of recalled drug administered in a patient who received HBV (Engerix B) (batch number CP23D, expiry date 31st December 2023) for prophylaxis.   On an unknown date, the patient received Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced recalled drug administered and product dispensing error. On an unknown date, the outcome of the recalled drug administered and product dispensing error were unknown.  Additional details provided were as follows: The age at vaccination was not reported. The patient received recalled dose of Engerix B which led to recalled drug administered and drug dispensing error. Immediately all the products were quarantined from this lot.  The product was stopped distributing and administering this lot only. The nurse asked if they need to inform patients and revaccinate them. The reporter consented to follow-up. This case is one of 10 case, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021222775:same reporter US-GLAXOSMITHKLINE-US2021AMR223912:same reporter US-GLAXOSMITHKLINE-US2021AMR223918:same reporter US-GLAXOSMITHKLINE-US2021AMR223919:same reporter US-GLAXOSMITHKLINE-US2021AMR223917:same reporter US-GLAXOSMITHKLINE-US2021AMR223916:same reporter US-GLAXOSMITHKLINE-US2021AMR223920:same reporter US-GLAXOSMITHKLINE-US2021AMR223914:same reporter US-GLAXOSMITHKLINE-US2021AMR223913:same reporter
Sex: U
Vaccine: HEP
Symptoms: Product dispensing error, Recalled product administered
Clinical narrative: lot number involved in a RECALL was administered; lot number involved in a RECALL was administered; This case was reported by a nurse via call center representative and described the occurrence of recalled drug administered in a patient who received HBV (Engerix B) (batch number CP23D, expiry date 31st December 2023) for prophylaxis.   On an unknown date, the patient received Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details provided were as follows: The age at vaccination was not reported. The nurse would like to know if 10 patients received Engerix-B of lot number CP23D and healthcare professional was sure that 10 patients received the vaccine because they completed the full vaccine box. The patient received recalled dose of Engerix B which led to recalled drug administered and drug dispensing error. Immediately all the product was quarantined from this lot. The product was stopped distributing and administering this lot only. The nurse asked do we need to inform patients and revaccinate them. The reporter consented to follow-up. This case was 1 of 10 linked cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR223920:same reporter US-GLAXOSMITHKLINE-US2021AMR223919:same reporter US-GLAXOSMITHKLINE-US2021AMR223916:same reporter US-GLAXOSMITHKLINE-US2021AMR223918:same reporter US-GLAXOSMITHKLINE-US2021AMR223912:same reporter US-GLAXOSMITHKLINE-US2021AMR223917:same reporter US-GLAXOSMITHKLINE-US2021AMR223914:same reporter US-GLAXOSMITHKLINE-US2021222775:same reporter US-GLAXOSMITHKLINE-US2021AMR223915:same reporter
Sex: U
Vaccine: HEP
Symptoms: Product dispensing error, Recalled product administered
Clinical narrative: lot number involved in a RECALL was administered; lot number involved in a RECALL was administered; This case was reported by a nurse via call center representative and described the occurrence of recalled drug administered in a patient who received HBV (Engerix B) (batch number CP23D, expiry date 31st December 2023) for prophylaxis.   On an unknown date, the patient received Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details provided were as follows: The age at vaccination was not reported. The nurse would like to know if 10 patients received Engerix-B of lot number CP23D and healthcare professional was sure that 10 patients received the vaccine because they completed the full vaccine box. The patient received recalled dose of Engerix B which led to recalled drug administered and drug dispensing error. Immediately all the product was quarantined from this lot. The product was stopped distributing and administering this lot only. The nurse asked do we need to inform patients and revaccinate them. The reporter consented to follow-up. This case was 1 of 10 linked cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR223919:same reporter US-GLAXOSMITHKLINE-US2021AMR223915:same reporter US-GLAXOSMITHKLINE-US2021222775:same reporter US-GLAXOSMITHKLINE-US2021AMR223916:same reporter US-GLAXOSMITHKLINE-US2021AMR223912:same reporter US-GLAXOSMITHKLINE-US2021AMR223918:same reporter US-GLAXOSMITHKLINE-US2021AMR223917:same reporter US-GLAXOSMITHKLINE-US2021AMR223920:same reporter US-GLAXOSMITHKLINE-US2021AMR223913:same reporter
Sex: U
Vaccine: HEP
Symptoms: Product dispensing error, Recalled product administered
Clinical narrative: lot number involved in a RECALL was administered; lot number involved in a RECALL was administered; This case was reported by a nurse via call center representative and described the occurrence of recalled drug administered in a patient who received HBV (Engerix B) (batch number CP23D, expiry date 31st December 2023) for prophylaxis.   On an unknown date, the patient received Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details provided were as follows: The age at vaccination was not reported. The nurse would like to know if 10 patients received Engerix-B of lot number CP23D and healthcare professional was sure that 10 patients received the vaccine because they completed the full vaccine box. The patient received recalled dose of Engerix B which led to recalled drug administered and drug dispensing error. Immediately all the product was quarantined from this lot. The product was stopped distributing and administering this lot only. The nurse asked do we need to inform patients and revaccinate them. The reporter consented to follow-up. This case was 1 of 10 linked cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021222775:same reporter US-GLAXOSMITHKLINE-US2021AMR223917:same reporter US-GLAXOSMITHKLINE-US2021AMR223918:same reporter US-GLAXOSMITHKLINE-US2021AMR223919:same reporter US-GLAXOSMITHKLINE-US2021AMR223916:same reporter US-GLAXOSMITHKLINE-US2021AMR223915:same reporter US-GLAXOSMITHKLINE-US2021AMR223914:same reporter US-GLAXOSMITHKLINE-US2021AMR223920:same reporter US-GLAXOSMITHKLINE-US2021AMR223913:same reporter
Sex: F
Vaccine: UNK, UNK
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: LINK TO VAERS #669833  Updating with patient death 11/3/2021
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Decreased appetite, Vomiting
Clinical narrative: Vomiting; administered with sterile water as a diluent; This is a spontaneous report from a contactable pharmacist. A 66-year-old male patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL3248; Expiration Date: Apr2021 ), via intramuscular, administered in Deltoid Left on 03Feb2021 14:00 (at the age of 66-years-old) as DOSE 2, 0.3ML SINGLE for covid-19 immunization. Medical history included, neoplasm malignant from an unknown date and unknown if ongoing Verbatim: Cancer, chemotherapy from an unknown date and unknown if ongoing Verbatim: Chemotherapy. Concomitant medication(s) included hydrocodone (HYDROCODONE) taken for an unspecified indication from an unspecified start date and ongoing; morphine (MORPHINE) taken for an unspecified indication from an unspecified start date and ongoing; pregabalin (PREGABALIN) taken for an unspecified indication from an unspecified start date and ongoing; potassium (POTASSIUM) taken for an unspecified indication from an unspecified start date and ongoing; sucralfate (SUCRALFATE) taken for an unspecified indication, start and stop date were not reported; prochlorperazine (PROCHLORPERAZINE) taken for an unspecified indication, start and stop date were not reported; pancreatin (CREON) taken for an unspecified indication, start and stop date were not reported; atropine sulfate, diphenoxylate hydrochloride (DIPHENOXYLATE/ATROPINE) taken for diarrhoea, start and stop date were not reported; ondansetron (ONDANSETRON) taken for an unspecified indication, start and stop date were not reported; ondansetron hydrochloride (ONDANSETRON ODT) taken for nausea, vomiting, start and stop date were not reported; prednisone (PREDNISONE) taken for an unspecified indication, start and stop date were not reported; hydrocodone bitartrate, paracetamol (HYDROCODONE/ACETAMINOPHEN) taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EJ1686; Expiration Date: Mar2021), via intramuscular, administered in Deltoid Left on 13Jan2021 13:28 (at the age of 66-years-old) as DOSE 1, SINGLE for covid-19 immunization. The patient administered with sterile water as a diluent on 03Feb2021, and vomiting on 05Feb2021 04:00. The outcome of the event was recovered on unspecified date in 2021.  Follow-up activities are not completed. No further information is expected.  Follow-up (08Mar2021): This is a follow-up spontaneous report received from a contactable Pharmacist. This Pharmacist reported in response to HCP letter sent that: included relevant medical history, concomitant medication, event vomiting.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021156535 same reporter/drug/event, different patient;US-PFIZER INC-2021156448 same reporter/drug/event, different patient;US-PFIZER INC-2021161873 same reporter/drug/event, different patient
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Vomiting; administered with sterile water as a diluent; This is a spontaneous report from a contactable pharmacist. A 66-year-old male patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL3248; Expiration Date: Apr2021 ), via intramuscular, administered in Deltoid Left on 03Feb2021 14:00 (at the age of 66-years-old) as DOSE 2, 0.3ML SINGLE for covid-19 immunization. Medical history included, neoplasm malignant from an unknown date and unknown if ongoing Verbatim: Cancer, chemotherapy from an unknown date and unknown if ongoing Verbatim: Chemotherapy. Concomitant medication(s) included hydrocodone (HYDROCODONE) taken for an unspecified indication from an unspecified start date and ongoing; morphine (MORPHINE) taken for an unspecified indication from an unspecified start date and ongoing; pregabalin (PREGABALIN) taken for an unspecified indication from an unspecified start date and ongoing; potassium (POTASSIUM) taken for an unspecified indication from an unspecified start date and ongoing; sucralfate (SUCRALFATE) taken for an unspecified indication, start and stop date were not reported; prochlorperazine (PROCHLORPERAZINE) taken for an unspecified indication, start and stop date were not reported; pancreatin (CREON) taken for an unspecified indication, start and stop date were not reported; atropine sulfate, diphenoxylate hydrochloride (DIPHENOXYLATE/ATROPINE) taken for diarrhoea, start and stop date were not reported; ondansetron (ONDANSETRON) taken for an unspecified indication, start and stop date were not reported; ondansetron hydrochloride (ONDANSETRON ODT) taken for nausea, vomiting, start and stop date were not reported; prednisone (PREDNISONE) taken for an unspecified indication, start and stop date were not reported; hydrocodone bitartrate, paracetamol (HYDROCODONE/ACETAMINOPHEN) taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EJ1686; Expiration Date: Mar2021), via intramuscular, administered in Deltoid Left on 13Jan2021 13:28 (at the age of 66-years-old) as DOSE 1, SINGLE for covid-19 immunization. The patient administered with sterile water as a diluent on 03Feb2021, and vomiting on 05Feb2021 04:00. The outcome of the event was recovered on unspecified date in 2021.  Follow-up activities are not completed. No further information is expected.  Follow-up (08Mar2021): This is a follow-up spontaneous report received from a contactable Pharmacist. This Pharmacist reported in response to HCP letter sent that: included relevant medical history, concomitant medication, event vomiting.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021156535 same reporter/drug/event, different patient;US-PFIZER INC-2021156448 same reporter/drug/event, different patient;US-PFIZER INC-2021161873 same reporter/drug/event, different patient
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Product preparation error, Vomiting
Clinical narrative: Vomiting; administered with sterile water as a diluent; This is a spontaneous report from a contactable pharmacist. A 66-year-old male patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL3248; Expiration Date: Apr2021 ), via intramuscular, administered in Deltoid Left on 03Feb2021 14:00 (at the age of 66-years-old) as DOSE 2, 0.3ML SINGLE for covid-19 immunization. Medical history included, neoplasm malignant from an unknown date and unknown if ongoing Verbatim: Cancer, chemotherapy from an unknown date and unknown if ongoing Verbatim: Chemotherapy. Concomitant medication(s) included hydrocodone (HYDROCODONE) taken for an unspecified indication from an unspecified start date and ongoing; morphine (MORPHINE) taken for an unspecified indication from an unspecified start date and ongoing; pregabalin (PREGABALIN) taken for an unspecified indication from an unspecified start date and ongoing; potassium (POTASSIUM) taken for an unspecified indication from an unspecified start date and ongoing; sucralfate (SUCRALFATE) taken for an unspecified indication, start and stop date were not reported; prochlorperazine (PROCHLORPERAZINE) taken for an unspecified indication, start and stop date were not reported; pancreatin (CREON) taken for an unspecified indication, start and stop date were not reported; atropine sulfate, diphenoxylate hydrochloride (DIPHENOXYLATE/ATROPINE) taken for diarrhoea, start and stop date were not reported; ondansetron (ONDANSETRON) taken for an unspecified indication, start and stop date were not reported; ondansetron hydrochloride (ONDANSETRON ODT) taken for nausea, vomiting, start and stop date were not reported; prednisone (PREDNISONE) taken for an unspecified indication, start and stop date were not reported; hydrocodone bitartrate, paracetamol (HYDROCODONE/ACETAMINOPHEN) taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EJ1686; Expiration Date: Mar2021), via intramuscular, administered in Deltoid Left on 13Jan2021 13:28 (at the age of 66-years-old) as DOSE 1, SINGLE for covid-19 immunization. The patient administered with sterile water as a diluent on 03Feb2021, and vomiting on 05Feb2021 04:00. The outcome of the event was recovered on unspecified date in 2021.  Follow-up activities are not completed. No further information is expected.  Follow-up (08Mar2021): This is a follow-up spontaneous report received from a contactable Pharmacist. This Pharmacist reported in response to HCP letter sent that: included relevant medical history, concomitant medication, event vomiting.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021156535 same reporter/drug/event, different patient;US-PFIZER INC-2021156448 same reporter/drug/event, different patient;US-PFIZER INC-2021161873 same reporter/drug/event, different patient
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acute myeloid leukaemia, Biopsy bone marrow, Full blood count
Clinical narrative: Some elevated CBC counts, Feb 4. Sore lower leg Feb 15.  Blood clot in leg Feb 16. AML diagnosis Feb 19. Ischemic stroke at base of brain stem Feb 21. Intubated Feb 21. Extubated and died Feb 23.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acute myeloid leukaemia, Death, Endotracheal intubation, Full blood count abnormal, Ischaemic stroke
Clinical narrative: Some elevated CBC counts, Feb 4. Sore lower leg Feb 15.  Blood clot in leg Feb 16. AML diagnosis Feb 19. Ischemic stroke at base of brain stem Feb 21. Intubated Feb 21. Extubated and died Feb 23.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Laboratory test, Pain in extremity, Thrombosis
Clinical narrative: Some elevated CBC counts, Feb 4. Sore lower leg Feb 15.  Blood clot in leg Feb 16. AML diagnosis Feb 19. Ischemic stroke at base of brain stem Feb 21. Intubated Feb 21. Extubated and died Feb 23.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acute myeloid leukaemia, Band neutrophil count, Band neutrophil count increased, Blast cell count increased, Blast cells
Clinical narrative: Some elevated CBC counts, Feb 4. Sore lower leg Feb 15.  Blood clot in leg Feb 16. AML diagnosis Feb 19. Ischemic stroke at base of brain stem Feb 21. Intubated Feb 21. Extubated and died Feb 23.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral haemorrhage, Disseminated intravascular coagulation, Haemorrhagic stroke, Ischaemic stroke, Leukaemia
Clinical narrative: Some elevated CBC counts, Feb 4. Sore lower leg Feb 15.  Blood clot in leg Feb 16. AML diagnosis Feb 19. Ischemic stroke at base of brain stem Feb 21. Intubated Feb 21. Extubated and died Feb 23.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Metamyelocyte count, Metamyelocyte count increased, Monocyte count, Monocyte count increased, Myelocyte count
Clinical narrative: Some elevated CBC counts, Feb 4. Sore lower leg Feb 15.  Blood clot in leg Feb 16. AML diagnosis Feb 19. Ischemic stroke at base of brain stem Feb 21. Intubated Feb 21. Extubated and died Feb 23.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Myelocyte count increased, Neutrophil count, Neutrophil count decreased, Pain in extremity, Platelet count
Clinical narrative: Some elevated CBC counts, Feb 4. Sore lower leg Feb 15.  Blood clot in leg Feb 16. AML diagnosis Feb 19. Ischemic stroke at base of brain stem Feb 21. Intubated Feb 21. Extubated and died Feb 23.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Red cell distribution width, Red cell distribution width increased, SARS-CoV-2 test, Thrombosis
Clinical narrative: Some elevated CBC counts, Feb 4. Sore lower leg Feb 15.  Blood clot in leg Feb 16. AML diagnosis Feb 19. Ischemic stroke at base of brain stem Feb 21. Intubated Feb 21. Extubated and died Feb 23.